Elevare works directly with founders and leadership teams to diagnose and fix the real operational breakdowns inside sales and GTM systems — not the symptoms, the source.
These aren't strategy failures. They're operational ones — and they're hiding in plain sight.
CRM is populated. Deals are moving. But closed-won isn't matching what the forecast said it would — quarter after quarter.
Discovery goes well. Proposals get sent. Then nothing. Reps are following up but deals sit in the same stage for weeks.
Leadership is adjusting numbers based on gut feel rather than system signals. Nobody fully trusts what the data says.
Activity is high. Calls are being made. Emails are going out. But the revenue line doesn't reflect the effort being put in.
Deal reviews feel like storytelling. There's no consistent framework for understanding why deals move — or why they don't.
The targeting looks right on paper. But meetings aren't converting into pipeline, and pipeline isn't converting into revenue.
If three or more of these sound familiar, the problem is structural. The Revenue Autopsy finds exactly where — and what's causing it.
Request a Revenue AutopsyEvery founder we've worked with came in thinking they had a pipeline problem, a hiring problem, or a messaging problem.
What they actually had was a systems problem.
Somewhere between the first meeting and the signed contract, the mechanics broke down. Deal stages didn't reflect reality. Forecasting logic was built on assumptions. Follow-through degraded as deals aged. Nobody had a clear view of where or why.
Elevare's work starts by looking at the actual mechanics of how revenue moves inside a company — not the slide deck version of it. We identify where deals get stuck, where visibility breaks down, and where execution drifts from intent.
See How We WorkMost companies want to know what they're signing up for before they commit. Here's exactly how the Autopsy runs.
Elevare reviews pipeline data, CRM structure, and deal stage definitions against actual buyer behavior and closed deal history.
Direct review of active deals, stall patterns, and qualification logic. Interviews with sales leadership and, where relevant, individual contributors.
Analysis of forecast inputs, historical accuracy, and the gap between submitted pipeline numbers and what actually closes.
Live readout session with Josh and your leadership team. Prioritized findings, structural issues identified, and a clear path forward.
Most engagements complete within 2–4 weeks depending on company size.
Elevare doesn't work with every company. The fit matters. Here's who gets the most out of this work.
You've been running revenue yourself. Now you're building a team and the system you had in your head needs to actually work without you.
Pipeline is there. Activity is there. But the conversion rate tells a different story. Something is broken in the middle of the funnel.
Leadership has stopped trusting the numbers. Forecasts are either sandbagged or optimistic — neither one matches what actually closes.
High activity, low output. The team is working hard but the revenue growth doesn't reflect it. The motion is there — the system isn't.
Most companies start with the Revenue Autopsy. It answers the question every other engagement depends on: what's actually broken?
A focused diagnostic engagement that finds the hidden breakdowns inside your revenue system. Elevare analyzes pipeline mechanics, deal progression, forecasting, and execution workflows — and tells you exactly where the constraints are.
Most companies are surprised by what it surfaces. Not because the problems are exotic — because nobody had looked at the system as a whole before.
Request a Revenue AutopsyTimeline: 2–4 weeks · Delivered by: Josh directly · Slots: Limited
Hands-on work fixing the operational breakdowns uncovered during the Revenue Autopsy. We don't just hand you a deck — we help implement the fix.
Direct strategic support for founders and leadership teams overseeing revenue. For operators who need a sharp outside perspective on a continuing basis.
"We weren't missing because of the market or the team. We were missing because the forecast was built on hope, not mechanics. Once we fixed the model, everything downstream got cleaner."
— CRO, Enterprise Technology CompanyPipeline was large on paper but deals consistently slipped past forecast dates. Leadership had no reliable signal for what would actually close.
Founder was running every deal personally. When they hired their first two salespeople, the sales motion didn't transfer — pipeline stalled immediately.
Board-level forecasts were being manually adjusted every week. Confidence in pipeline data was so low that leadership defaulted to gut feel for resource planning.
Josh DeLucia spent over a decade in enterprise sales leadership, managing large revenue cycles across SaaS, professional services, and B2B technology companies. He sat in the pipeline reviews. He rebuilt the broken forecasts. He coached founders through the transition from founder-led sales to scalable teams.
What he kept seeing — company after company — was the same pattern: intelligent people, good products, genuine effort. And stalled revenue that nobody could fully explain. The answers were almost never in the strategy deck. They were in the mechanics.